HB 534 Kentucky House · 2024 Regular Session

AN ACT relating to addiction treatment.

Summary

Amend KRS 205.536 to prohibit the Department for Medicaid Services or a Medicaid managed care organization from requiring or using certain utilization reviews for prescription drugs that contain Naloxone; amend KRS 304.17A-611 to prohibit insurers from requiring or using certain utilization reviews for prescription drugs that contain Naloxone.

Bill status signed all 5 stages cleared

Introduction

Feb 2024

Committee Review

Mar 2024

House Passage

Mar 2024

Senate Passage

Mar 2024

Signed into Law

Apr 2024

Introduced Feb 14, 2024 Signed Apr 9, 2024

Floor votes · House Mar 6, 2024

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 9, 2024

Signed into law

signed by Governor (Acts Ch. 155)

lower

Mar 28, 2024

Upper · Passed

enrolled, signed by President of the Senate

upper

Mar 28, 2024

Lower · Passed

enrolled, signed by Speaker of the House

lower

Mar 28, 2024

Lower · Passed

3rd reading, passed 37-1

lower

Mar 27, 2024

Lower · Passed

passed over and retained in the Consent Orders of the Day

lower

Mar 26, 2024

Lower · Passed

passed over and retained in the Consent Orders of the Day

lower

Mar 21, 2024

Lower · Passed

reported favorably, 1st reading, to Consent Calendar

lower

Mar 13, 2024

Committee

to Banking & Insurance (S)

upper

Mar 7, 2024

Committee

to Committee on Committees (S)

upper

Mar 6, 2024

Lower · Passed

3rd reading, passed 94-0 with Committee Substitute (1)

lower

Feb 29, 2024

Lower · Passed

reported favorably, 1st reading, to Calendar with Committee Substitute (1)

lower

Feb 23, 2024

Committee

to Health Services (H)

lower

Feb 14, 2024

Committee

to Committee on Committees (H)

lower

Feb 14, 2024

Introduced

introduced in House

lower

1 primary · 0 co-sponsors